AMBROSE KRISTEN (SVP & Chief Accounting Officer) sold 8.9% of their position (884.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $425.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2025ACC: 0000875320-25-000103
Officer· SVP & Chief Accounting Officer
Since May 2021
-1.71K
Net shares
Net seller
$825.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−828.00
Price / share
$483.28
Trade value
$400.16K
% of position
7.7%
2/24/2025
10.80K→9.97K
Common Stock
Direct
Shares
−884.00
Price / share
$480.95
Trade value
$425.16K
% of position
8.9%
2/25/2025
9.97K→9.09K
Total
Net shares
−1.71K
Net value
-$825.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | F · Tax Withholding | −828.00 | $483.28 | $400.16K | 7.7% | 10.80K | 9.97K |
| Common Stock Direct | 2/25/2025 | S · Sale | −884.00 | $480.95 | $425.16K | 8.9% | 9.97K | 9.09K |
| Total | −1.71K | -$825.32K | ||||||
Derivative Transactions0
No derivative transactions reported